De novo myelodysplastic syndrome in a Rothmund-Thomson Syndrome patient with novel pathogenic RECQL4 variants
Rothmund-Thomson syndrome (RTS) is a rare autosomal-recessive disorder with clinical features consisting of rash, poikiloderma, sparse hair, short stature, juvenile cataracts, skeletal abnormalities, and cancer predisposition. Genetic studies involving detection of pathogenic RECQL4 variants provide...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health
2023-04-01
|
Series: | Blood Science |
Online Access: | http://journals.lww.com/10.1097/BS9.0000000000000152 |
_version_ | 1797817598182686720 |
---|---|
author | Chuanhe Jiang Hao Zhang Chuxian Zhao Luxiang Wang Xiaoxia Hu Zengkai Pan |
author_facet | Chuanhe Jiang Hao Zhang Chuxian Zhao Luxiang Wang Xiaoxia Hu Zengkai Pan |
author_sort | Chuanhe Jiang |
collection | DOAJ |
description | Rothmund-Thomson syndrome (RTS) is a rare autosomal-recessive disorder with clinical features consisting of rash, poikiloderma, sparse hair, short stature, juvenile cataracts, skeletal abnormalities, and cancer predisposition. Genetic studies involving detection of pathogenic RECQL4 variants provide the diagnostic certitude. Osteosarcoma was found in two-thirds RECQL4-mutated RTS patients, while hematological malignancies were rarely reported. The variant diversity of RECQL4 gene has not been fully identified and mutations associated with hematologic malignancies are not well described. In this study, we presented a pedigree of RTS from a Chinese family, among which the proband was diagnosed with de novo myelodysplastic syndrome (MDS). Comprehensive medical examination and chromosome karyotyping were performed on the proband. Whole exome sequencing (WES) was performed on the proband, his sister and his mother. The familial cosegregation of sequence variants derived from WES was conducted by polymerase chain reaction–based Sanger sequencing. Structures of candidate RECQL4 mutants were done by in silico analysis to assess pathogenicity. Three novel RECQL4 germline variants, including c.T274C, c.G3014A, and c.G801C, were identified by WES and validated by Sanger sequencing. Prediction of conformation indicated that the structural stability of human RECQL4 protein was largely affected with these variants. The co-occurring U2AF1 p.S34F and TP53 p.Y220C mutations might contribute to the development of MDS. Our study expands the mutational spectrum of RECQL4 and provides underlying molecular mechanism for the development of MDS in RTS patients. |
first_indexed | 2024-03-13T08:55:54Z |
format | Article |
id | doaj.art-ea7bd5ee5593442ca4b3170566256c0b |
institution | Directory Open Access Journal |
issn | 2543-6368 |
language | English |
last_indexed | 2024-03-13T08:55:54Z |
publishDate | 2023-04-01 |
publisher | Wolters Kluwer Health |
record_format | Article |
series | Blood Science |
spelling | doaj.art-ea7bd5ee5593442ca4b3170566256c0b2023-05-29T03:32:21ZengWolters Kluwer HealthBlood Science2543-63682023-04-015212513010.1097/BS9.0000000000000152202304000-00008De novo myelodysplastic syndrome in a Rothmund-Thomson Syndrome patient with novel pathogenic RECQL4 variantsChuanhe Jiang0Hao Zhang1Chuxian Zhao2Luxiang Wang3Xiaoxia Hu4Zengkai Pan5a National Research Center for Translational Medicine, State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, Chinaa National Research Center for Translational Medicine, State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, Chinab Shanghai Zhaxin Traditional Chinese & Western Medicine Hospital, Shanghai 200435, Chinaa National Research Center for Translational Medicine, State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, Chinaa National Research Center for Translational Medicine, State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, Chinaa National Research Center for Translational Medicine, State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaRothmund-Thomson syndrome (RTS) is a rare autosomal-recessive disorder with clinical features consisting of rash, poikiloderma, sparse hair, short stature, juvenile cataracts, skeletal abnormalities, and cancer predisposition. Genetic studies involving detection of pathogenic RECQL4 variants provide the diagnostic certitude. Osteosarcoma was found in two-thirds RECQL4-mutated RTS patients, while hematological malignancies were rarely reported. The variant diversity of RECQL4 gene has not been fully identified and mutations associated with hematologic malignancies are not well described. In this study, we presented a pedigree of RTS from a Chinese family, among which the proband was diagnosed with de novo myelodysplastic syndrome (MDS). Comprehensive medical examination and chromosome karyotyping were performed on the proband. Whole exome sequencing (WES) was performed on the proband, his sister and his mother. The familial cosegregation of sequence variants derived from WES was conducted by polymerase chain reaction–based Sanger sequencing. Structures of candidate RECQL4 mutants were done by in silico analysis to assess pathogenicity. Three novel RECQL4 germline variants, including c.T274C, c.G3014A, and c.G801C, were identified by WES and validated by Sanger sequencing. Prediction of conformation indicated that the structural stability of human RECQL4 protein was largely affected with these variants. The co-occurring U2AF1 p.S34F and TP53 p.Y220C mutations might contribute to the development of MDS. Our study expands the mutational spectrum of RECQL4 and provides underlying molecular mechanism for the development of MDS in RTS patients.http://journals.lww.com/10.1097/BS9.0000000000000152 |
spellingShingle | Chuanhe Jiang Hao Zhang Chuxian Zhao Luxiang Wang Xiaoxia Hu Zengkai Pan De novo myelodysplastic syndrome in a Rothmund-Thomson Syndrome patient with novel pathogenic RECQL4 variants Blood Science |
title | De novo myelodysplastic syndrome in a Rothmund-Thomson Syndrome patient with novel pathogenic RECQL4 variants |
title_full | De novo myelodysplastic syndrome in a Rothmund-Thomson Syndrome patient with novel pathogenic RECQL4 variants |
title_fullStr | De novo myelodysplastic syndrome in a Rothmund-Thomson Syndrome patient with novel pathogenic RECQL4 variants |
title_full_unstemmed | De novo myelodysplastic syndrome in a Rothmund-Thomson Syndrome patient with novel pathogenic RECQL4 variants |
title_short | De novo myelodysplastic syndrome in a Rothmund-Thomson Syndrome patient with novel pathogenic RECQL4 variants |
title_sort | de novo myelodysplastic syndrome in a rothmund thomson syndrome patient with novel pathogenic recql4 variants |
url | http://journals.lww.com/10.1097/BS9.0000000000000152 |
work_keys_str_mv | AT chuanhejiang denovomyelodysplasticsyndromeinarothmundthomsonsyndromepatientwithnovelpathogenicrecql4variants AT haozhang denovomyelodysplasticsyndromeinarothmundthomsonsyndromepatientwithnovelpathogenicrecql4variants AT chuxianzhao denovomyelodysplasticsyndromeinarothmundthomsonsyndromepatientwithnovelpathogenicrecql4variants AT luxiangwang denovomyelodysplasticsyndromeinarothmundthomsonsyndromepatientwithnovelpathogenicrecql4variants AT xiaoxiahu denovomyelodysplasticsyndromeinarothmundthomsonsyndromepatientwithnovelpathogenicrecql4variants AT zengkaipan denovomyelodysplasticsyndromeinarothmundthomsonsyndromepatientwithnovelpathogenicrecql4variants |